Editor-in-Chief

Wenhua Liang, MD

Thoracic oncology, the First Affiliated Hospital of Guangzhou Medical University, China State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, Guangzhou, China

Dr. Wenhua Liang graduated from the Cancer Center of Sun Yat-sen University in 2014 as an outstanding graduate. He is now a Chief Physician, Professor, and PhD Tutor, dedicated to the management of lung cancer and relevant clinical/translational research. Since 2012, he has published 330+ SCI research articles (cumulative IF > 2900, citations > 28,000, H-index 50), with 240+ as a key author in top-tier journals such as JAMA, Lancet Oncology (2022/2023), Journal of Clinical Oncology (2015/2017), Lancet Digital Health, NEJM, BMJ, Journal of Thoracic Oncology, Journal of Clinical Investigation, and Thorax. An active international presenter, he has delivered 15+ oral presentations at conferences including ASCO, ESMO, and WCLC, and received an ASCO Merit Award. Additionally, he has led 8 nationwide multicenter clinical trials as principal investigator (PI) or sub-PI.

He is the recipient of The National Science Fund for Excellent Young Scholars (Oncology), and he serves as Chairman of the Immunotherapy Committee of Guangdong Association of Thoracic Disease, Director of the Lung Cancer Group of the Chinese National Clinical Research Center for Respiratory Disease, a member of several prestigious academic organizations (CACA, CSCO, ASCO, ESMO, and IASLC), and Associate Editor of Translational Lung Cancer Research.

He been recognized with several honors, including Best Youth Doctor of China (2019), DAMO Academy Young Fellow (2020), and inclusion in the Stanford-Elsevier top 2% scholars career list.